Overview.
Perimenopause is the natural transition from reproductive to non-reproductive life, lasting an average of 4-8 years before the final menstrual period. FSH rises and becomes variable, estradiol fluctuates erratically, and progesterone declines. Hormone levels alone are neither sensitive nor specific enough to diagnose or stage the transition. Premature ovarian insufficiency (POI), occurring before age 40, is a distinct and more serious condition.
As the ovarian follicular pool depletes, inhibin B falls, removing the FSH brake. FSH rises and becomes variable. Estradiol is erratic — often paradoxically high in early perimenopause before declining in late perimenopause. Progesterone declines with increasing anovulatory cycles. This hormonal instability drives vasomotor, mood, sleep, and menstrual symptoms. Menopause is defined as 12 consecutive months without a period.
Prevalence: Universal in women with intact ovaries. Median age of natural menopause in the US/Western Europe is ~51 years. Perimenopause typically begins 4-8 years prior (median onset ~47). Approximately 10% of women experience an abrupt transition (<2 years).
Medical name: Perimenopause / Menopausal Transition
Symptoms.
Early warnings
- Subtle changes in cycle length (shorter first, then more variable)
- Increased PMS-like symptoms
- Sleep disturbances and new insomnia
- Mild hot flushes or night sweats
- Changes in menstrual flow
- New mood instability, anxiety, or low mood
Classic symptoms
- Vasomotor symptoms: hot flushes and night sweats (affects 75-80%)
- Irregular menstrual cycles (cardinal sign)
- Sleep disruption and insomnia
- Mood changes (depression, anxiety, irritability)
- Vaginal dryness and genitourinary symptoms
- Cognitive changes and brain fog
- Weight gain and body composition changes
- Joint aches
- Reduced libido
- Breast tenderness
Progression
Perimenopause is a physiological transition lasting 2-10 years. Vasomotor symptoms can persist 7-10 years post-menopause in some women. Long-term consequences of estrogen withdrawal include bone loss, cardiovascular risk increase, genitourinary syndrome, and cognitive changes.
Risk factors.
- Smoking (earlier menopause by 1-2 years)
- Chemotherapy or pelvic radiation
- Ovarian surgery (accelerates transition)
- Family history of early menopause
- Low BMI
Lab interpretation.
Key biomarkers
- FSH — Rising and highly variable in early perimenopause (10-25 IU/L); markedly elevated and less variable in late transition (>25 IU/L); consistently >40 IU/L in postmenopause. Single result unreliable for staging. (primary)
- Estradiol (E2) — Erratic — can be paradoxically elevated (>200 pg/mL) in early perimenopause; declining to <50 pg/mL in late transition; <20-30 pg/mL postmenopause (primary)
- LH — Gradually rising; less variable than FSH; not routinely required for diagnosis (secondary)
- AMH — Very low or undetectable throughout perimenopause; earlier decline than FSH rise; useful in younger women to assess reserve trajectory (secondary)
- Progesterone — Declining with increasing anovulatory cycles; very low in late perimenopause and postmenopause (secondary)
- TSH — Should be checked to exclude thyroid dysfunction, which mimics perimenopausal symptoms (exclusion)
Diagnostic criteria
- Aged 45+: Clinical diagnosis based on irregular periods and typical symptoms — hormone testing generally not required
- Aged <45: Hormone testing required to distinguish from premature ovarian insufficiency (POI)
- FSH >25 IU/L with amenorrhea in a woman <40 = investigate for POI, not perimenopause
- Menopause confirmed retrospectively: 12 consecutive months without a period, no other cause
- Always exclude: pregnancy, thyroid dysfunction, hyperprolactinemia
Recommended panels
When & next steps.
When to test
- Symptoms of menopause transition in a woman under 45 (to exclude POI)
- Hysterectomy without oophorectomy (cannot use menstrual pattern for staging)
- On hormonal contraception masking cycles, with menopausal symptoms
- Atypical presentation or diagnostic uncertainty
- History of unexplained amenorrhea under 40
If suspected
- In women 45+: clinical diagnosis — no routine hormone testing required (NAMS 2022)
- Rule out pregnancy (essential)
- Check TSH to exclude thyroid dysfunction
- Check prolactin if prominent menstrual irregularity
- Assess symptom severity and impact on quality of life
If confirmed
- Hormone therapy (HT): most effective treatment for vasomotor symptoms; favorable benefit-risk if initiated within 10 years of menopause before age 60 (NAMS 2022)
- Non-hormonal options: SSRIs/SNRIs, gabapentin for vasomotor symptoms
- Lifestyle: regular exercise, sleep hygiene, reduce alcohol and smoking
- Bone health: calcium, vitamin D, DEXA at confirmed menopause (especially if early)
- Cardiovascular risk monitoring: lipid profile, blood pressure, lifestyle
FAQs.
Do I need blood tests to know if I am perimenopausal?
For women 45 and over with typical symptoms — irregular periods, hot flushes, night sweats — the diagnosis is clinical and blood tests are generally not needed or recommended (NAMS 2022, NICE 2024). Hormone levels are too variable during this time to be reliably diagnostic. Testing is most useful under 45 to exclude premature ovarian insufficiency.
Can I still get pregnant during perimenopause?
Yes. While fertility declines significantly, ovulation can still occur unpredictably during perimenopause. Contraception should be continued until 12 months after the final menstrual period if over 50, or 24 months if under 50.
What is the difference between perimenopause and menopause?
Menopause is defined retrospectively as 12 consecutive months without a period (with no other cause). Perimenopause is the transition period before that point, which can last years. You only know you were in perimenopause once you reach the 12-month mark without a period.